ID-Liver

FARSITE allowed the ID-Liver study team to identify patients across GP practices with specific risk factors, to identify patients with the potential to develop liver disease.

Through its ability to run tailored searches and streamline GP engagement, FARSITE helped the ID-Liver study rapidly recruit over 1,000 patients from diverse demographics and minimise the workload for busy primary care teams. This enabled the research team to focus on early detection, using FibroScan, biomarker analysis, and AI-driven risk prediction tools to create a new, scalable diagnostic pathway that could transform liver disease screening across Greater Manchester and beyond. The result is a replicable model that reduces costs, improves recruitment efficiency, and has the potential to significantly improve patient outcomes.

To read the full case study, please click here.